With Colts' training camp on the horizon, who are the best available NFL free agents that are still out there?

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

As the clock ticks down on June, savvy investors are eyeing the top tokens to buy before the month ends. One new name is stealing the spotlight, Mutuum Finance (MUTM). The project retails for $0.03 at ...

Sony India today introduced its latest innovation, the BRAVIA 2 II series featuring 4K Ultra HD LED display technology, ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and challenges shaping SMMT's future.

One-time surgical application of genetically engineered autologous keratinocyte sheets provides significant closure and pain ...

Wuthering Waves has released the second phase of its version 2.4 update featuring the Flames of Heart quest alongside a new 5 ...

Star. The Mariners’ catcher won Phase 2 of the PRO SPIRIT MLB All-Star Ballot that closed on Wednesday morning over Toronto’s ...

Council members spent most of the day behind closed doors in executive session, but spent the final hour questioning officials about the potential impact of the legislation.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...